Glaucoma Drainage Device Erosions in Patients Receiving Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy

PURPOSE: To determine if intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections are associated with an increased risk of glaucoma drainage device (GDD) erosions. PATIENTS AND METHODS: A retrospective chart review was conducted including patients with diabetic retinopathy and had...

Descripción completa

Detalles Bibliográficos
Autores principales: Islam, Yasmin Florence Khodeja, Vanner, Elizabeth A, Maharaj, Arindel S R, Schwartz, Stephen G, Kishor, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657253/
https://www.ncbi.nlm.nih.gov/pubmed/36389643
http://dx.doi.org/10.2147/OPTH.S386033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657253/
https://www.ncbi.nlm.nih.gov/pubmed/36389643
http://dx.doi.org/10.2147/OPTH.S386033

Ejemplares similares